Home/Specialty/Neurology/Computerized Behavioral Therapy Device For Substance Use Disorders/reSET-O®

PEAR THERAPEUTICS, INC. 1 reSET-O®

Company Name

PEAR THERAPEUTICS, INC.

Catalog Number

1

Description

reSET-O® is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

Have questions or need more information? Contact Us

Pricing
Summary

Price Not Available

Out of Stock

Interested in this product?
Contact us or login to add to your watchlist.

Related Items

PEAR THERAPEUTICS, INC. 1.1 reSET-O™

reSET-O Mobile Application runs on Android. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only Mobile Medical Application.Limitations of Use: reSET-O has not been shown to decrease illicit drug use or improve abstinence in patients with OUD.

PEAR THERAPEUTICS, INC. 1 reSET®

reSET® is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12 week (90 days) prescription-only treatment for patients with substance use disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to:- increase abstinence from a patient’s substances of abuse during treatment, and- increase retention in the outpatient treatment program.

PEAR THERAPEUTICS, INC. 1 reSET® Non-Monetary CM

reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12-week (90 days) prescriptiononly treatment for patients with Substance Use Disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to: increase abstinence from a patient’s substances of abuse during treatment, and increase retention in the outpatient treatment program This configuration of reSET is intended to provide virtual incentives to patients based on the Contingency management system.

Yellofin Elite Leg Holder Lift-Assist Stirrups w/ Cart

Key features of the Baxter Hillrom Yellofin stirrups typically include: Lithotomy Positioning: Provides reliable lithotomy positioning with a boot-like design for the lower legs, allowing secure support while minimizing nerve stress. Self-adjusting Boot: The boot is designed to automatically adjust to the patient's anatomy, reducing the risk of pressure injuries. Lift Assist Mechanism: It features an assist mechanism to make leg adjustments smoother and easier for medical personnel. Enhanced Safety: Some models include a secure locking system that prevents unintentional adjustments during surgery. Durability: Made from high-grade materials to ensure longevity and withstand repeated sterilization. This system is widely used in OR environments for its precision and ergonomic advantages for both patients and clinicians.

PEAR THERAPEUTICS, INC. 1 reSET-O® Mobile App, iOS

reSET-O® Mobile Application running on iOS. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

PEAR THERAPEUTICS, INC. 1 reSET-O® Mobile App, Android

reSET-O® Mobile Application running on Android. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

PEAR THERAPEUTICS, INC. 1 reSET-O®

reSET-O is intended to increase retention of patients with Opioid Use Disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic. This configuration of reSET-O is intended to provide virtual incentives as well as monetary incentives to the patients based on the Contingency management system.

PEAR THERAPEUTICS, INC. 1 reSET-O® Non-Monetary CM

reSET-O is intended to increase retention of patients with Opioid Use Disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic. This configuration of reSET-O is intended to provide virtual incentives to patients based on the Contingency management system.

PEAR THERAPEUTICS, INC. 1.1 reSET-O™

reSET-O Mobile Application runs on iOS. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only Mobile Medical Application.Limitations of Use: reSET-O has not been shown to decrease illicit drug use or improve abstinence in patients with OUD.

PEAR THERAPEUTICS, INC. 1.1 reSET-O™

reSET-O Mobile Application runs on Android. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only Mobile Medical Application.Limitations of Use: reSET-O has not been shown to decrease illicit drug use or improve abstinence in patients with OUD.

PEAR THERAPEUTICS, INC. 1 reSET®

reSET® is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12 week (90 days) prescription-only treatment for patients with substance use disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to:- increase abstinence from a patient’s substances of abuse during treatment, and- increase retention in the outpatient treatment program.

PEAR THERAPEUTICS, INC. 1 reSET® Non-Monetary CM

reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12-week (90 days) prescriptiononly treatment for patients with Substance Use Disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to: increase abstinence from a patient’s substances of abuse during treatment, and increase retention in the outpatient treatment program This configuration of reSET is intended to provide virtual incentives to patients based on the Contingency management system.

Yellofin Elite Leg Holder Lift-Assist Stirrups w/ Cart

Key features of the Baxter Hillrom Yellofin stirrups typically include: Lithotomy Positioning: Provides reliable lithotomy positioning with a boot-like design for the lower legs, allowing secure support while minimizing nerve stress. Self-adjusting Boot: The boot is designed to automatically adjust to the patient's anatomy, reducing the risk of pressure injuries. Lift Assist Mechanism: It features an assist mechanism to make leg adjustments smoother and easier for medical personnel. Enhanced Safety: Some models include a secure locking system that prevents unintentional adjustments during surgery. Durability: Made from high-grade materials to ensure longevity and withstand repeated sterilization. This system is widely used in OR environments for its precision and ergonomic advantages for both patients and clinicians.

PEAR THERAPEUTICS, INC. 1 reSET-O® Mobile App, iOS

reSET-O® Mobile Application running on iOS. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

PEAR THERAPEUTICS, INC. 1 reSET-O® Mobile App, Android

reSET-O® Mobile Application running on Android. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

PEAR THERAPEUTICS, INC. 1 reSET-O®

reSET-O is intended to increase retention of patients with Opioid Use Disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic. This configuration of reSET-O is intended to provide virtual incentives as well as monetary incentives to the patients based on the Contingency management system.

PEAR THERAPEUTICS, INC. 1 reSET-O® Non-Monetary CM

reSET-O is intended to increase retention of patients with Opioid Use Disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic. This configuration of reSET-O is intended to provide virtual incentives to patients based on the Contingency management system.

PEAR THERAPEUTICS, INC. 1.1 reSET-O™

reSET-O Mobile Application runs on iOS. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only Mobile Medical Application.Limitations of Use: reSET-O has not been shown to decrease illicit drug use or improve abstinence in patients with OUD.

PEAR THERAPEUTICS, INC. 1.1 reSET-O™

reSET-O Mobile Application runs on Android. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only Mobile Medical Application.Limitations of Use: reSET-O has not been shown to decrease illicit drug use or improve abstinence in patients with OUD.

PEAR THERAPEUTICS, INC. 1 reSET®

reSET® is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12 week (90 days) prescription-only treatment for patients with substance use disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to:- increase abstinence from a patient’s substances of abuse during treatment, and- increase retention in the outpatient treatment program.

PEAR THERAPEUTICS, INC. 1 reSET® Non-Monetary CM

reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12-week (90 days) prescriptiononly treatment for patients with Substance Use Disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to: increase abstinence from a patient’s substances of abuse during treatment, and increase retention in the outpatient treatment program This configuration of reSET is intended to provide virtual incentives to patients based on the Contingency management system.

Additional Details

Device Identifier

10851580008101

Is RX

Yes

Is Over the Counter

No

Requires Sterilization

No

Is Sterile

No

Is Single Use

No

Categories

Barcode Mapping

Unit of Measurement	Eaches	GTIN
Each	1	10851580008101
Each	1	96439-0020-01